272 related articles for article (PubMed ID: 4207590)
1. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
[TBL] [Abstract][Full Text] [Related]
2. Prevention of rhesus immunization in Australia. The first seven years.
Davey MG
Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of Rh sensitization using anti-D immunoglobulin. (An 8 year study)].
Spoljarić I; Majnarić M
Jugosl Ginekol Opstet; 1978; 18(5-6):417-22. PubMed ID: 119891
[TBL] [Abstract][Full Text] [Related]
4. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
5. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
Hindemann P; Hinselmann M; Frey P
Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
[No Abstract] [Full Text] [Related]
6. Prevention of Rh hemolytic disease of the newborn.
Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
[TBL] [Abstract][Full Text] [Related]
7. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
Bowen FW; Renfield M
Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
Frey P; Hinselmann M; Hindemann P
Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
[No Abstract] [Full Text] [Related]
9. [Hemolytic disease of the newborn due to anti-S-antibodies].
Gligorović VN; Gligorović S; Veselinović I; Milosević M
Bilt Hematol Transfuz; 1977; 5(1):51-7. PubMed ID: 411482
[TBL] [Abstract][Full Text] [Related]
10. [Anti-D prevention. Review and outlook for 1976].
Schneider J
Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
[No Abstract] [Full Text] [Related]
11. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
12. Rho (D) immune prophylaxis. A double-blind cooperative study.
White CA; Visscher RD; Visscher HC; Wade ME
Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961
[No Abstract] [Full Text] [Related]
13. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)].
Börner P; Deicher H; Bähr I; Chelius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
Dtsch Med Wochenschr; 1977 May; 102(20):745-51. PubMed ID: 405190
[TBL] [Abstract][Full Text] [Related]
15. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
[TBL] [Abstract][Full Text] [Related]
16. Rh-prophylaxis with immunoglobulin anti-D administered during pregnancy and after delivery.
Hermann M; Kjellman H
Acta Obstet Gynecol Scand Suppl; 1976; 49():1-11. PubMed ID: 816170
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
Gligorović VN; Gligorović S; Susaković N; Lopicić L; Stolić I; Marković V; Matejić T
Bilt Hematol Transfuz; 1976; 4(3):23-31. PubMed ID: 827283
[TBL] [Abstract][Full Text] [Related]
18. [Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)].
Börner P; Deicher H; Bähr I; Chalius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):485-92. PubMed ID: 820591
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
[TBL] [Abstract][Full Text] [Related]
20. [Successes and failures in rhesus-prophylaxis].
Speiser P
Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
